Clinical Trial Update: A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof [Phase 3]

View source ↗

Summary

Phase 3 study evaluating intravenous iron isomaltoside 1000 (Monofer) given by infusion to non-anaemic patients undergoing cardiac surgery (CABG, valve replacem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Valvular Heart Disease

Drugs mentioned

• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Non-anaemic Patients Undergoing Cardiac Surgery | Phase 3 | Status: COMPLETED